Gestational Protein Restriction Delays Prostate Morphogenesis In Male Rats

Maternal malnutrition due to a low-protein diet is associated with functional disorders in adulthood, which may be related to embryonic development failures. The effects of gestational protein restriction on prostate morphogenesis in male offspring were investigated. Pregnant rat dams were divided into normoprotein (NP; fed a normal diet containing 17% protein) and hypoprotein (LP; fed a diet containing 6% protein) groups. On the day of birth (PND1), anogenital distance and bodyweight were measured in male pups. Seven males per experimental group (one male per litter) were killed, and the pelvic urethra was evaluated. LP offspring showed a significant reduction in bodyweight and anogenital distance on PND1. On three-dimensional reconstruction of the prostate, the number of prostatic buds was lower in LP than in NP males. Mesenchymal cells surrounding the buds were androgen-receptor positive, and the quantity and intensity of nucleus immunoreactivity was decreased in LP. The proliferation index was lower in LP than in NP prostatic buds. Immunoreactivity for α-actin in mesenchymal cells and that for epidermal growth factor receptor in epithelial cells was higher in NP than in LP. Our findings demonstrate that maternal protein restriction delays prostatic morphogenesis, probably because of considerable disruption in the epithelium-mesenchyme interaction. © 2014 CSIRO.267967973Barker, D.J., In utero programming of cardiovascular disease (2000) Theriogenology, 53, pp. 555-574. , doi:10.1016/S0093-691X(99)00258-7Cónsole, G.M., Jurado, S.B., Oyhenart, E., Ferese, C., Pucciarelli, H., Gómez Dumm, C.L., Morphometric and ultrastructural analysis of different pituitary cell populations in undernourished monkeys (2001) Braz. J. Med. Biol. Res., 34, pp. 65-74. , doi:10.1590/S0100- 879X2001000100008Cooke, P.S., Young, P., Cunha, G.R., Androgen receptor expression in developing male reproductive organs (1991) Endocrinology, 128, pp. 2867-2873. , doi:10.1210/ENDO-128-6-2867Cunha, G.R., Alarid, E.T., Turner, T., Donjacour, A.A., Boutin, E.L., Foster, B.A., Normal and abnormal development of the male urogenital tract: Role of androgens, mesenchymal-epithelial interactions and growth factors (1992) J. Androl., 13, pp. 465-475Cunha, G.R., Foster, B., Thomson, A., Sugimura, Y., Tanji, N., Tsuji, M., Terada, N., Donjacour, A.A., Growth factors as mediators of androgen action during the development of the male urogenital tract (1995) World J. Urol., 13, pp. 264-276. , doi:10.1007/ BF00185969Da Silva Faria, T., Da Fonte Ramos, C., Sampaio, F.J., Puberty onset in the female offspring of rats submitted to protein or energy restricted diet during lactation (2004) J. Nutr. Biochem., 15, pp. 123-127. , doi:10.1016/J.JNUTBIO.2003.08.011Desai, M., Crowther, N.J., Lucas, A., Hales, C.N., Organselective growth in the offspring of protein-restricted mothers (1996) Br. J. Nutr., 76, pp. 591-603. , doi:10.1079/BJN19960065Fagundes, A.T., Moura, E.G., Passos, M.C.F., Oliveira, E., Toste, F.P., Bonomo, I.T., Trevenzoli, I.H., Lisboa, P.C., Maternal low-protein diet during lactation programmes body composition and glucose homeostasis in the adult rat offspring (2007) Br. J. Nutr., 98, pp. 922-928. , doi:10.1017/S0007114507750924Gardner, D.S., Ozanne, S.E., Sinclair, K.D., Effect of the earlylife nutritional environment on fecundity and fertility of mammals (2009) Philos. Trans. R. Soc. Lond. B Biol. Sci., 364, pp. 3419-3427. , doi:10.1098/ RSTB.2009.0121Gosby, A.K., Stanton, L.M.L., Maloney, C.A., Thompson, M., Briody, J., Baxter, R.C., Bryson, J.M., Caterson, I.D., Postnatal nutrition alters body composition in adult offspring exposed to maternal protein restriction (2009) Br. J. Nutr., 101 (12), pp. 1878-1884. , doi:10.1017/S0007114508135851Graham, S., Gandelman, R., The expression of anogenital distance data in the mouse (1986) Physiol. Behav., 36, pp. 103-104. , doi:10.1016/ 0031-9384(86)90081-8Hayashi, N., Sugimura, Y., Kawamura, J., Donjacour, A.A., Cunha, G.R., Morphological and functional heterogeneity in the rat prostatic gland (1991) Biol. Reprod., 45, pp. 308-321. , doi:10.1095/BIOLREPROD45.2.308Lucas, A., Programming by early nutrition: An experimental approach (1998) J. Nutr., 128, pp. 401S-406SMarker, P.C., Donjacour, A.A., Dahiya, R., Cunha, G.R., Hormonal, cellular and molecular control of prostatic development (2003) Dev. Biol., 253, pp. 165-174. , doi:10.1016/S0012-1606(02)00031-3McMillen, I.C., Maclaughlin, S.M., Muhlhausler, B.S., Gentili, S., Duffield, J.L., Morrison, J.L., Developmental origins of adult health and disease: The role of periconceptional and foetal nutrition (2008) Basic Clin. Pharmacol. Toxicol., 102, pp. 82-89. , doi:10.1111/J.1742-7843. 2007.00188.XPage, K.C., Sottas, C.M., Hardy, M.P., Prenatal exposure to dexamethasone alters Leydig cell steroidogenic capacity in immature and adult rats (2001) J. Androl., 22, pp. 973-980Prins, G.S., Birch, L., The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to oestrogen (1995) Endocrinology, 136, pp. 1303-1314. , doi:10.1210/ EN.136.3.1303Prins, G.S., Cooke, P.S., Birch, L., Donjacour, A.A., Yalcinkaya, T.M., Siiteri, P.K., Cunha, G.R., Androgen receptor expression and 5a-reductase activity along the proximal-distal axis of the rat prostatic duct (1992) Endocrinology, 130, pp. 3066-3073. , doi:10.1210/EN.130.5.3066Prins, G.S., Birch, L., Habermann, H., Chang, W.Y., Tebeau, C., Putz, O., Bieberich, C., Influence of neonatal oestrogens on rat prostate development (2001) Reprod. Fertil. Dev., 13, pp. 241-252. , doi:10.1071/RD00107Puchtler, H., Waldrop, F.S., Meloan, S.N., Terry, M.S., Conner, H.M., Methacarn (methanol-carnoy) fixation: Practical and theoretical considerations (1970) Histochemie, 21, pp. 97-116. , doi:10.1007/BF00306176Reeves, P.G., Nielsen, F.H., Fahey, G.C., AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76 rodent diet (1993) J. Nutr., 123, pp. 1939-1951Rinaldi, J.C., Justulin, L.A., Lacorte, L.M., Sarobo, C., Boer, P.A., Scarano, W.R., Felisbino, S.L., Implications of intrauterine protein malnutrition on prostate growth, maturation and aging (2013) Life Sci., 92, pp. 763-774. , doi:10.1016/J.LFS.2013.02.007Santos, F.C.A., Leite, R.P., Custódio, A.M.G., Carvalho, K.P., Monteiro- Leal, L.H., Santos, A.B., Goes, R.M., Taboga, S.R., Testosterone stimulates growth and secretory activity of the female prostate in the adult gerbil (Meriones unguiculatus) (2006) Biol. Reprod., 75, pp. 370-379. , doi:10.1095/BIOLREPROD.106.051789Scarano, W.R., Toledo, F.C., Guerra, M.T., Campos, S.G.P., Justulin Jr., L.A., Felisbino, S.L., Anselmo-Franci, J.A., Kempinas, W.G., Long-term effects of developmental exposure to di-N-butyl-phthalate (DBP) on rat prostate: Proliferative and inflammatory disorders and a possible role of androgens (2009) Toxicology, 262 (3), pp. 215-223. , doi:10.1016/J.TOX.2009.06.011Sugimura, Y., Cunha, G.R., Donjacour, A.A., Morphogenesis of ductal networks in the mouse prostate (1986) Biol. Reprod., 34, pp. 961-971. , doi:10.1095/BIOLREPROD34.5.961Swan, S.H., Main, K.M., Liu, F., Stewart, S.L., Kruse, R.L., Calafat, A.M., Mao, C.S., Teague, J.L., Decrease in ano-genital distance among male infants with prenatal phthalate exposure (2005) Environ. Health Perspect., 113, pp. 1056-1061. , doi:10.1289/EHP.8100Thomson, A.A., Role of androgens and fibroblast growth factors in prostatic development (2001) Reproduction, 121, pp. 187-195. , doi:10.1530/REP. 0.1210187Thomson, A.A., Cunha, G.R., Prostatic growth and development are regulated by FGF10 (1999) Development, 126, pp. 3693-3701Timms, B.G., Prostate development: A historical perspective (2008) Differentiation, 76, pp. 565-577. , doi:10.1111/J.1432-0436.2008.00278.XTimms, B.G., Mohs, T.J., Didio, L.J., Ductal budding and branching patterns in the developing prostate (1994) J. Urol., 151, pp. 1427-1432Vilamaior, P.S.L., Taboga, S.R., Carvalho, H.F., Postnatal growth of the ventral prostate in Wistar rats: A stereological and morphometrical study (2006) Anat. Rec. A Discov. Mol. Cell. Evol. Biol., 288 A, pp. 885-892. , doi:10.1002/AR.A.20363Wang, Y., Hayward, S., Cao, M., Thayer, K., Cunha, G.R., Cell differentiation lineage in the prostate (2001) Differentiation, 68, pp. 270-279. , doi:10.1046/J.1432-0436.2001.680414.XWoodham, C., Birch, L., Prins, G.S., Neonatal oestrogen downregulates prostatic androgen receptor through a proteosome-mediated protein degradation pathway (2003) Endocrinology, 144, pp. 4841-4850. , doi:10.1210/EN.2003-0035Zambrano, E., Rodrigez-González, G.L., Guzmán, C., García-Becerra, R., Boeck, L., Díaz, L., Menjivar, M., Nathanielsz, P.W., A maternal low-protein diet during pregnancy and lactation in the rat impairs male reproductive development (2005) J. Physiol., 563, pp. 275-284. , doi:10.1113/JPHYSIOL.2004.07854

Melatonin Attenuates The Tlr4-mediated Inflammatory Response Through Myd88- And Trif-dependent Signaling Pathways In An In Vivo Model Of Ovarian Cancer

Background: Toll-like receptors (TLRs) are effector molecules expressed on the surface of ovarian cancer (OC) cells, but the functions of the TLR2/TLR4 signaling pathways in these cells remain unclear. Melatonin (mel) acts as an anti-inflammatory factor and has been reported to modulate TLRs in some aggressive tumor cell types. Therefore, we investigated OC and the effect of long-term mel therapy on the signaling pathways mediated by TLR2 and TLR4 via myeloid differentiation factor 88 (MyD88) and toll-like receptor-associated activator of interferon (TRIF) in an ethanol-preferring rat model. Methods: To induce OC, the left ovary of animals either consuming 10% (v/v) ethanol or not was injected directly under the bursa with a single dose of 100μg of 7,12-dimethylbenz(a)anthracene (DMBA) dissolved in 10 μL of sesame oil. The right ovaries were used as sham-surgery controls. After developing OC, half of the animals received i.p. injections of mel (200 μg/100 g b.w./day) for 60 days. Results: Although mel therapy was unable to reduce TLR2 levels, it was able to suppress the OC-associated increase in the levels of the following proteins: TLR4, MyD88, nuclear factor kappa B (NFkB p65), inhibitor of NFkB alpha (IkBα), IkB kinase alpha (IKK-α), TNF receptor-associated factor 6 (TRAF6), TRIF, interferon regulatory factor 3 (IRF3), interferon β (IFN-β), tumor necrosis factor alpha (TNF-α), and interleukin (IL)-6. In addition, mel significantly attenuated the expression of IkBα, NFkB p65, TRIF and IRF-3, which are involved in TLR4-mediated signaling in OC during ethanol intake. Conclusion: Collectively, our results suggest that mel attenuates the TLR4-induced MyD88- and TRIF-dependent signaling pathways in ethanol-preferring rats with OC.151Cannistra, S.A., Cancer of the ovary (2004) N Engl J Med, 351, pp. 2519-2565Fallows, S., Price, J., Atkinson, R.J., Johnston, P.G., Hickey, I., Russell, S.E., P53 mutation does not affect prognosis in ovarian epithelial malignancies (2001) J Pathol, 194, pp. 68-75Kelly, M.G., Alvero, A.B., Chen, R., Silasi, D.A., Abrahams, V.M., Chan, S., TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer (2006) Cancer Res, 66, pp. 3859-3868Chen, R., Alvero, A.B., Silasi, D.A., Steffensen, K.D., Mor, G., Cancers take their toll-the function and regulation of toll-like receptors in cancer cells (2008) Oncogene, 27, pp. 225-233Szajnik, M., Szczepanski, M.J., Czystowska, M., Elishaev, E., Mandapathil, M., Nowak-Markwitz, E., TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer" (2009) Oncogene, 28, pp. 4353-4363Wang, A.C., Su, Q.B., Wu, F.X., Zhang, X.L., Liu, P.S., Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells (2009) Eur J Clin Invest, 39, pp. 157-164Hsu, D., Fukata, M., Hernandez, Y.G., Sotolongo, J.P., Goo, T., Maki, J., Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury (2010) Lab Invest, 90, pp. 1295-1305Beinke, S., Ley, S.C., Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology (2004) Biochem J, 382, pp. 393-409Akira, S., Toll-like receptor signaling (2003) J Biol Chem, 278, pp. 38105-38108Akira, S., Takeda, K., Toll-like receptor signalling (2004) Nat Rev Immunol, 4, pp. 499-511French, S.W., Oliva, J., French, B.A., Li, J., Bardag-Gorce, F., Alcohol, nutrition and liver cancer: role of Toll-like receptor signaling (2010) World J Gastroenterol, 16, pp. 1344-1348Chuffa, L.G., Fioruci-Fontanelli, B.A., Mendes, L.O., Fávaro, W.J., Pinheiro, P.F., Martinez, M., Characterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatment (2013) PLoS One, 8, p. e81676Ferreira, G.M., Martinez, M., Camargo, I.C., Domeniconi, R.F., Martinez, F.E., Chuffa, L.G., Melatonin attenuates Her-2, p38 MAPK, p-AKT, and mTOR levels in ovarian carcinoma of ethanol-preferring rats (2014) J Cancer Educ, 5, pp. 728-735Stehle, J.H., Saade, A., Rawashdeh, O., Ackermann, K., Jilg, A., Sebestény, T., A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases (2011) J Pineal Res, 51, pp. 17-43Blask, D.E., Dauchy, R.T., Sauer, L.A., Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal (2005) Endocrine, 27, pp. 179-188Cos, S., González, A., Martínez-Campa, C., Mediavilla, M.D., Alonso-González, C., Sánchez-Barceló, E.J., Melatonin as a selective estrogen enzyme modulator (2008) Curr Cancer Drug Targets, 8, pp. 691-702Petranka, J., Baldwin, W., Biermann, J., Jayadev, S., Barrett, J.C., Murphy, E., The oncostatic action of melatonin in an ovarian carcinoma cell line (1999) J Pineal Res, 26, pp. 129-136Reiter, R.J., Mechanisms of cancer inhibition by melatonin (2004) J Pineal Res, 3, pp. 213-214Calvo, J.R., González-Yanes, C., Maldonado, M.D., The role of melatonin in the cells of the innate immunity: a review (2013) J Pineal Res, 55, pp. 103-120Hu, Z.P., Fang, X.L., Fang, N., Wang, X.B., Qian, H.Y., Cao, Z., Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4/NF-jB system in high-fat-fed rabbits (2013) J Pineal Res, 55, pp. 388-398Tamura, E.K., Cecon, E., Monteiro, A.W., Silva, C.L., Markus, R.P., Melatonin inhibits LPS-induced NO production in rat endothelial cells (2009) J Pineal Res, 46, pp. 268-274Mauriz, J.L., Collado, P.S., Veneroso, C., Reiter, R.J., González-Gallego, J., A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives (2013) J Pineal Res, 54, pp. 1-14Conti, A., Maestroni, G.J., The clinical neuroimmunotherapeutic role of melatonin in oncology (1995) J Pineal Res, 19, pp. 103-110Chada, S., Ramesh, R., Mhashilkar, A.M., Cytokine- and chemokine-based gene therapy for cancer (2003) Curr Opin Mol Ther, 5, pp. 463-474Kang, J.W., Koh, E.J., Lee, S.M., Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll-like receptor signaling pathway (2011) J Pineal Res, 50, pp. 403-411Chuffa, L.G., Amorim, J.P., Teixeira, G.R., Mendes, L.O., Fioruci, B.A., Pinheiro, P.F., Long-term exogenous melatonin treatment modulates overall feed efficiency and protects ovarian tissue against injuries caused by ethanol-induced oxidative stress in adult UChB rats (2011) Alcohol Clin Exp Res, 35, pp. 1498-1508Chuffa, L.G., Seiva, F.R., Fávaro, W.J., Amorim, J.P., Teixeira, G.R., Mendes, L.O., Melatonin and ethanol intake exert opposite effects on circulating estradiol and progesterone and differentially regulate sex steroid receptors in the ovaries, oviducts, and uteri of adult rats (2013) Reprod Toxicol, 39, pp. 40-49Chuffa, L.G., Seiva, F.R., Fávaro, W.J., Teixeira, G.R., Amorim, J.P., Mendes, L.O., Melatonin reduces LH, 17 beta-estradiol and induces differential regulation of sex steroid receptors in reproductive tissues during rat ovulation (2011) Reprod Biol Endocrinol, 9, p. 108Chuffa, L.G., Amorim, J.P., Teixeira, G.R., Mendes, L.O., Fioruci, B.A., Pinheiro, P.F., Long-term melatonin treatment reduces ovarian mass and enhances tissue antioxidant defenses during ovulation in the rat (2011) Braz J Med Biol Res, 44, pp. 217-223Hoyer, P.B., Davis, J.R., Bedrnicek, J.B., Marion, S.L., Christian, P.J., Barton, J.K., Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure (2009) Gynecol Oncol, 112, pp. 610-615Zhou, M., McFarland-Mancini, M.M., Funk, H.M., Husseinzadeh, N., Mounajjed, T., Drew, A.F., Toll-like receptor expression in normal ovary and ovarian tumors (2009) Cancer Immunol Immunother, 58, pp. 1375-1385Xia, M.Z., Liang, Y.L., Wang, H., Chen, X., Huang, Y.Y., Zhang, Z.H., Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells (2012) J Pineal Res, 53, pp. 325-334Lucas, K., Maes, M., Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway (2013) Mol Neurobiol, 48, pp. 190-204Fernandez-Lizarbe, S., Montesinos, J., Guerri, C., Ethanol induces TLR4/TLR2 association, triggering an inflammatory response in microglial cells (2013) J Neurochem, 126, pp. 261-273O'Neill, L.A., Fitzgerald, K.A., Bowie, A.G., The Toll-IL-1 receptor adaptor family grows to five members (2003) Trends Immunol, 24, pp. 286-290Wang, Z., Wu, L., You, W., Ji, C., Chen, G., Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway (2013) J Pineal Res, 55, pp. 399-408Wagnerberger, S., Fiederlein, L., Kanuri, G., Stahl, C., Millonig, G., Mueller, S., Sex-specific differences in the development of acute alcohol-induced liver steatosis in mice (2013) Alcohol Alcohols, 48, pp. 648-656Natoli, G., Chiocca, S., Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation. (2008) Sci Signal, 1Barlin, J.N., Jelinic, P., Olvera, N., Bogomolniy, F., Bisogna, M., Dao, F., Validated gene targets associated with curatively treated advanced serous ovarian carcinoma (2013) Gynecol Oncol, 128, pp. 512-517Landen, C.N., Birrer, M.J., Sood, A.K., Early events in the pathogenesis of epithelial ovarian cancer (2008) J Clin Oncol, 26, pp. 995-1005Kim, J.M., Kim, S.H., Ko, S.H., Jung, J., Chun, J., Kim, N., The guggulsterone derivative GG-52 inhibits NF-ΚB signaling in gastric epithelial cells and ameliorates ethanol-induced gastric mucosal lesions in mice (2013) Am J Physiol Gastrointest Liver Physiol, 304, pp. G193-202Blanco, A.M., Guerri, C., Ethanol intake enhances inflammatory mediators in brain: role of glial cells and TLR4/IL-1RI receptors (2007) Front Biosci, 12, pp. 2616-2630Kim, W.H., Hong, F., Jaruga, B., Hu, Z., Fan, S., Liang, T.J., Additive activation of hepatic NF-Κ B by ethanol and HBX or HCV core protein: involvement of TNF-α receptor I-independent and -dependent mechanisms (2001) FASEB J, 15, pp. 2551-2553Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K., Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling (2003) J Immunol, 171, pp. 4304-4310Fitzgerald, K.A., McWhirter, S.M., Faia, K.L., Rowe, D.C., Latz, E., Golenbock, D.T., IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway (2003) Nat Immunol, 4, pp. 491-496Muccioli, M., Sprague, L., Nandigam, H., Pate, M., Benencia, F., Toll-like receptors as novel therapeutic targets for ovarian cancer (2012) ISRN Oncol, 2012, p. 642141Petrasek, J., Dolganiuc, A., Csak, T., Nath, B., Hritz, I., Kodys, K., Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells (2011) Hepatology, 53, pp. 649-660Ruegg, C., Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions (2006) J Leukoc Biol, 80, pp. 682-684Santin, A.D., Hermonat, P.L., Ravaggi, A., Cannon, M.J., Pecorelli, S., Parham, G.P., Secretion of vascular endothelial growth factor in ovarian cancer (1999) Eur J Gynaecol Oncol, 20, pp. 177-181Garcia-Mauriño, S., Gonzalez-Haba, M.G., Calvo, J.R., Rafii-El-Idrissi, M., Sanchez-Margalet, V., Goberna, R., Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: A possible nuclear receptor-mediated mechanism involving Thelper type 1 lymphocytes and monocytes (1997) J Immunol, 159, pp. 574-58

CMS physics technical design report: Addendum on high density QCD with heavy ions

This report presents the capabilities of the CMS experiment to explore the rich heavy-ion physics programme offered by the CERN Large Hadron Collider (LHC). The collisions of lead nuclei at energies ,will probe quark and gluon matter at unprecedented values of energy density. The prime goal of this research is to study the fundamental theory of the strong interaction - Quantum Chromodynamics (QCD) - in extreme conditions of temperature, density and parton momentum fraction (low-x). This report covers in detail the potential of CMS to carry out a series of representative Pb-Pb measurements. These include "bulk" observables, (charged hadron multiplicity, low pT inclusive hadron identified spectra and elliptic flow) which provide information on the collective properties of the system, as well as perturbative probes such as quarkonia, heavy-quarks, jets and high pT hadrons which yield "tomographic" information of the hottest and densest phases of the reaction.0info:eu-repo/semantics/publishe